TrialThe Journal of biological chemistry2014

Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-β (TGF-β) signaling promoting SMAD3 activation and fibrosis via Gremlin protein.

Steven O'Reilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.